ICON to acquire PRA Health Sciences
Deal creates a world leader in healthcare intelligence and clinical research
Read moreICON supports Pfizer and BioNTech on COVID-19 vaccine trial
Trial capabilities key to enabling agility and speed in global study involving 44,000 subjects
Read the press releaseBest CRO at the Vaccine Industry Excellence Awards
Recognises ICON’s long-standing vaccine development expertise.
Read the press releaseICON launches Accellacare
Global research network offering integrated solutions of patient assessments at site and in-home for decentralised trials
Read the press release